49
Views
23
CrossRef citations to date
0
Altmetric
Review Article

CD95 Antigen Mutations in Hematopoietic Malignancies

, , , , , & show all
Pages 835-846 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Vanesa Scholl, Claudio Gustavo Stefanoff, Rocio Hassan, Nelson Spector & Ilana Zalcberg Renault. (2007) Mutations within the 5′ region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma. Leukemia & Lymphoma 48:5, pages 957-963.
Read now
Faris QB Alenzi, Richard KH Wyse & Waleed G Altamimi. (2004) Apoptosis as a tool for therapeutic agents in haematological diseases. Expert Opinion on Biological Therapy 4:3, pages 407-420.
Read now

Articles from other publishers (21)

Khalid A. Asseri & Afaf Ahmed Aldahish. 2023. Molecular Targets and Cancer Therapeutics (Part 1). Molecular Targets and Cancer Therapeutics (Part 1) 12 51 .
Kamil Seyrek, Fabian Wohlfromm, Johannes Espe & Inna N. Lavrik. (2022) The cross-talk of autophagy and apoptosis in breast carcinoma: implications for novel therapies?. Biochemical Journal 479:14, pages 1581-1608.
Crossref
Senthilkumar Kalimuthu & Kim Se-Kwon. (2013) Cell Survival and Apoptosis Signaling as Therapeutic Target for Cancer: Marine Bioactive Compounds. International Journal of Molecular Sciences 14:2, pages 2334-2354.
Crossref
Lissbeth Leon-Bollotte, Selvakumar Subramaniam, Olivier Cauvard, Stéphanie Plenchette–Colas, Catherine Paul, Cindy Godard, Antonio Martinez–Ruiz, Patrick Legembre, Jean–François Jeannin & Ali Bettaieb. (2011) S-Nitrosylation of the Death Receptor Fas Promotes Fas Ligand–Mediated Apoptosis in Cancer Cells. Gastroenterology 140:7, pages 2009-2018.e4.
Crossref
Anastasios Chatzitolios, Ioannis Venizelos, Gregory Tripsiannis, George Anastassopoulos & Nikolaos Papadopoulos. (2010) Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin’s lymphoma. Annals of Hematology 89:9, pages 889-896.
Crossref
Prasanthi Karna & Lily Yang. 2009. Apoptosis in Carcinogenesis and Chemotherapy. Apoptosis in Carcinogenesis and Chemotherapy 1 23 .
Wendy F. Davidson, Partha Mukhopadhyay, Mark S. Williams, Zohreh Naghashfar, Jeff X. Zhou & Herbert C. MorseIIIIII. 2008. National Institute of Allergy and Infectious Diseases, NIH. National Institute of Allergy and Infectious Diseases, NIH 385 396 .
Eisaku Kondo & Tadashi Yoshino. (2007) Expression of apoptosis regulators in germinal centers and germinal center-derived B-cell lymphomas: Insight into B-cell lymphomagenesis. Pathology International 57:7, pages 391-397.
Crossref
Marie Bénéteau, Sophie Daburon, Jean-François Moreau, Jean-Luc Taupin & Patrick Legembre. (2007) Dominant-Negative Fas Mutation Is Reversed by Down-expression of c-FLIP. Cancer Research 67:1, pages 108-115.
Crossref
Bulent Eser, Ismail Sari, Ozlem Canoz, Fevzi Altuntas, Erol Cakmak, Ahmet Ozturk, Metin Ozkan, Ozlem Er, Mustafa Cetin & Ali Unal. (2006) Prognostic significance of Fas (CD95/APO‐1) positivity in patients with primary nodal diffuse large B‐cell lymphoma. American Journal of Hematology 81:5, pages 307-314.
Crossref
Brigitte M.T. Hougardy, Ate G.J. van der Zee, Fiona A.J. van den Heuvel, Tineke Timmer, Elisabeth G.E. de Vries & Steven de Jong. (2005) Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: Relationship with Fas, caspase-8, and Bid. Gynecologic Oncology 97:2, pages 353-364.
Crossref
Lily Yang. 2005. Application of Apoptosis to Cancer Treatment. Application of Apoptosis to Cancer Treatment 1 28 .
Katrin U. Lundin, Valentina Screpanti, Hilde Omholt, Peter O. Hofgaard, Hideo Yagita, Alf Grandien & Bjarne Bogen. (2004) CD4+ T cells kill Id+ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo. Cancer Immunology, Immunotherapy 53:12, pages 1135-1145.
Crossref
Jan Braess, Peter Schneiderat, Claudia Schoch, Michael Fiegl, Isolde Lorenz & Wolfgang Hiddemann. (2004) Functional analysis of apoptosis induction in acute myeloid leukaemia-relevance of karyotype and clinical treatment response. British Journal of Haematology 126:3, pages 338-347.
Crossref
Klaus-Michael Debatin & Peter H Krammer. (2004) Death receptors in chemotherapy and cancer. Oncogene 23:16, pages 2950-2966.
Crossref
Catriona H. M. Jamieson, Emmanuelle Passegué & Irving L. Weissman. 2004. Stem Cells in the Nervous System: Functional and Clinical Implications. Stem Cells in the Nervous System: Functional and Clinical Implications 157 182 .
Emmanuelle Passegué, Catriona H. M. Jamieson, Laurie E. Ailles & Irving L. Weissman. (2003) Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?. Proceedings of the National Academy of Sciences 100:suppl_1, pages 11842-11849.
Crossref
Anthony W Tolcher. (2002) Regulators of apoptosis as anticancer targets. Hematology/Oncology Clinics of North America 16:5, pages 1255-1267.
Crossref
Wolfram V. Bernstorff, Jonathan N. Glickman, Robert D. Odze, Francis A. Farraye, Hong G. Joo, Peter S. Goedegebuure & Timothy J. Eberlein. (2002) Fas (CD95/APO‐1) and Fas ligand expression in normal pancreas and pancreatic tumors. Cancer 94:10, pages 2552-2560.
Crossref
Jeffrey C Rathmell & Craig B Thompson. (2002) Pathways of Apoptosis in Lymphocyte Development, Homeostasis, and Disease. Cell 109:2, pages S97-S107.
Crossref
Kenneth H. Shain, Terry H. Landowski & William S. Dalton. (2002) Adhesion-Mediated Intracellular Redistribution of c-Fas-Associated Death Domain-Like IL-1-Converting Enzyme-Like Inhibitory Protein-Long Confers Resistance to CD95-Induced Apoptosis in Hematopoietic Cancer Cell Lines. The Journal of Immunology 168:5, pages 2544-2553.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.